Lawson Kroeker Investment Management Inc Pfizer Inc Transaction History

Lawson Kroeker Investment Management Inc

$516 Million
Q3 2024

A detailed history of Lawson Kroeker Investment Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Lawson Kroeker Investment Management Inc holds 218,311 shares of PFE stock, worth $5.81 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares

218,311

Previous 222,661 1.95%

Holding current value

$5.81 Million

Previous $6.23 Million 1.4%

% of portfolio

1.22%

Previous 1.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $120,495 - $136,546	-4,350 Reduced 1.95%	218,311 $6.32 Million
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $2,020 - $2,368	-80 Reduced 0.04%	222,661 $6.23 Million
Q1 2024 Apr 22, 2024	SELL	$25.89 - $29.73 $202,848 - $232,934	-7,835 Reduced 3.4%	222,741 $6.18 Million
Q4 2023 Jan 29, 2024	SELL	$26.13 - $33.94 $266,944 - $346,731	-10,216 Reduced 4.24%	230,576 $6.64 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $40,914 - $47,825	1,275 Added 0.53%	240,792 $7.99 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $62,306 - $72,087	1,725 Added 0.73%	239,517 $8.79 Million
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $309,211 - $402,548	-7,850 Reduced 3.2%	237,792 $9.7 Million
Q4 2022 Jan 17, 2023	SELL	$41.75 - $54.5 $11,481 - $14,987	-275 Reduced 0.11%	245,642 $0
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $4,376 - $5,342	-100 Reduced 0.04%	245,917 $10.8 Million
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $1.09 Million - $1.29 Million	-23,450 Reduced 8.7%	246,017 $12.9 Million
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $22,875 - $28,345	-500 Reduced 0.19%	269,467 $14 Million
Q4 2021 Jan 10, 2022	SELL	$41.32 - $61.25 $31,072 - $46,060	-752 Reduced 0.28%	269,967 $15.9 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $274,161 - $352,183	-6,985 Reduced 2.52%	270,719 $11.6 Million
Q2 2021 Jul 12, 2021	SELL	$35.91 - $40.68 $87,620 - $99,259	-2,440 Reduced 0.87%	277,704 $10.9 Million
Q1 2021 Apr 09, 2021	SELL	$33.49 - $37.77 $18,252 - $20,584	-545 Reduced 0.19%	280,144 $10.2 Million
Q4 2020 Jan 13, 2021	SELL	$33.47 - $42.56 $39,159 - $49,795	-1,170 Reduced 0.42%	280,689 $10.3 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $329,723 - $386,841	10,385 Added 3.83%	281,859 $10.3 Million
Q2 2020 Jul 13, 2020	SELL	$30.12 - $36.54 $9,036 - $10,962	-300 Reduced 0.11%	271,474 $8.88 Million
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $11,082 - $15,834	410 Added 0.15%	271,774 $8.87 Million
Q4 2019 Jan 16, 2020	SELL	$32.92 - $37.36 $140,074 - $158,966	-4,255 Reduced 1.54%	271,364 $10.6 Million
Q3 2019 Oct 08, 2019	SELL	$32.49 - $42.13 $719,653 - $933,179	-22,150 Reduced 7.44%	275,619 $9.9 Million
Q2 2019 Jul 16, 2019	SELL	$36.98 - $41.52 $40,678 - $45,672	-1,100 Reduced 0.37%	297,769 $12.9 Million
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $200,812 - $220,626	-5,355 Reduced 1.76%	298,869 $12.7 Million
Q4 2018 Jan 15, 2019	SELL	$38.47 - $43.86 $127,989 - $145,922	-3,327 Reduced 1.08%	304,224 $13.3 Million
Q3 2018 Oct 12, 2018	SELL	$34.47 - $41.81 $22,060 - $26,758	-640 Reduced 0.21%	307,551 $13.6 Million
Q2 2018 Jul 16, 2018	SELL	$32.98 - $35.16 $36,442 - $38,851	-1,105 Reduced 0.36%	308,191 $11.2 Million
Q1 2018 Apr 17, 2018	SELL	$31.91 - $37.02 $19,465 - $22,582	-610 Reduced 0.2%	309,296 $11 Million
Q4 2017 Jan 17, 2018	SELL	$33.26 - $35.29 $812,408 - $861,993	-24,426 Reduced 7.31%	309,906 $11.2 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $10.4 Million - $11.4 Million	334,332	334,332 $11.9 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lawson Kroeker Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lawson Kroeker Investment Management Inc with notifications on news.

Account

Lawson Kroeker Investment Management Inc Pfizer Inc Transaction History